chr3-15478979-T-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_005677.4(COLQ):āc.391A>Gā(p.Lys131Glu) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.000339 in 1,614,164 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (ā ā ).
Frequency
Consequence
NM_005677.4 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
COLQ | NM_005677.4 | c.391A>G | p.Lys131Glu | missense_variant, splice_region_variant | 5/17 | ENST00000383788.10 | |
COLQ | NM_080538.2 | c.361A>G | p.Lys121Glu | missense_variant, splice_region_variant | 5/17 | ||
COLQ | NM_080539.4 | c.289A>G | p.Lys97Glu | missense_variant, splice_region_variant | 4/16 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
COLQ | ENST00000383788.10 | c.391A>G | p.Lys131Glu | missense_variant, splice_region_variant | 5/17 | 1 | NM_005677.4 | P4 |
Frequencies
GnomAD3 genomes AF: 0.000335 AC: 51AN: 152154Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000247 AC: 62AN: 251354Hom.: 0 AF XY: 0.000258 AC XY: 35AN XY: 135840
GnomAD4 exome AF: 0.000340 AC: 497AN: 1461892Hom.: 0 Cov.: 31 AF XY: 0.000338 AC XY: 246AN XY: 727248
GnomAD4 genome AF: 0.000335 AC: 51AN: 152272Hom.: 0 Cov.: 32 AF XY: 0.000282 AC XY: 21AN XY: 74460
ClinVar
Submissions by phenotype
Congenital myasthenic syndrome 5 Uncertain:3
Uncertain significance, criteria provided, single submitter | clinical testing | Baylor Genetics | Aug 14, 2018 | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Jan 14, 2020 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 23, 2022 | This sequence change replaces lysine, which is basic and polar, with glutamic acid, which is acidic and polar, at codon 131 of the COLQ protein (p.Lys131Glu). This variant is present in population databases (rs142980906, gnomAD 0.04%). This variant has not been reported in the literature in individuals affected with COLQ-related conditions. ClinVar contains an entry for this variant (Variation ID: 197779). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Not Available"; Align-GVGD: "Class C55"). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Aug 01, 2020 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Jan 20, 2015 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at